•
Sep 30, 2023

Stryker Q3 2023 Earnings Report

Stryker reported strong organic sales growth and continued margin expansion in Q3 2023.

Key Takeaways

Stryker's Q3 2023 results showed a 9.6% increase in reported net sales, reaching $4.9 billion. Organic net sales grew by 9.2%. The adjusted EPS increased by 16.0% to $2.46.

Reported net sales increased 9.6% to $4.9 billion.

Organic net sales increased 9.2%.

Adjusted EPS increased 16.0% to $2.46.

Company expects full year 2023 organic net sales growth to be in the range of 10.0% to 10.5%.

Total Revenue
$4.91B
Previous year: $4.48B
+9.6%
EPS
$2.46
Previous year: $2.12
+16.0%
Organic Net Sales Growth
9.2%
Previous year: 9.9%
-7.1%
Gross Profit
$3.16B
Previous year: $2.78B
+13.5%
Cash and Equivalents
$1.86B
Previous year: $1.42B
+31.0%
Free Cash Flow
$902M
Previous year: $751M
+20.1%
Total Assets
$38B
Previous year: $36B
+5.7%

Stryker

Stryker

Stryker Revenue by Geographic Location

Forward Guidance

Stryker expects full year 2023 organic net sales growth to be in the range of 10.0% to 10.5% including slightly positive pricing for the year. Adjusted net earnings per diluted share are expected to be in the range of $10.35 to $10.45.

Positive Outlook

  • Robust backlog for capital equipment
  • Continued positive procedural trends

Challenges Ahead

  • Foreign exchange rates may unfavorably impact net sales by approximately 0.6% for the full year
  • Adjusted net earnings per diluted share will be unfavorably impacted by $0.10 to $0.15 for the full year due to foreign exchange rates

Revenue & Expenses

Visualization of income flow from segment revenue to net income